These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2566000)
1. Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen. Gaskell DJ; Hawkins RA; Sangsterl K; Chetty U; Forrest AP Lancet; 1989 May; 1(8646):1044-6. PubMed ID: 2566000 [TBL] [Abstract][Full Text] [Related]
2. Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates. Coombes RC; Powles TJ; Berger U; Wilson P; McClelland RA; Gazet JC; Trott PA; Ford HT Lancet; 1987 Sep; 2(8561):701-3. PubMed ID: 2888939 [TBL] [Abstract][Full Text] [Related]
3. ERICA predicts response to tamoxifen in elderly women with breast cancer. Davies N; Moir G; Carpenter R; Cuthbert A; Herbert A; Royle GT; Taylor I Ann R Coll Surg Engl; 1991 Nov; 73(6):361-3. PubMed ID: 1759765 [TBL] [Abstract][Full Text] [Related]
4. The use of fine-needle aspirates of breast cancers to evaluate hormone-receptor status. Lundy J; Lozowski M; Sadri D; Mishriki Y Arch Surg; 1990 Feb; 125(2):174-6. PubMed ID: 2302058 [TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas. Skoog L; Humla S; Isaksson S; Tani E Diagn Cytopathol; 1990; 6(2):95-8. PubMed ID: 2186900 [TBL] [Abstract][Full Text] [Related]
6. The differing predictive values of oestrogen receptor assays for large breast cancers. Gaskell DJ; Hawkins RA; Tesdale AL; Sangster K; Chetty U; Forrest AP Postgrad Med J; 1992 Nov; 68(805):900-3. PubMed ID: 1494511 [TBL] [Abstract][Full Text] [Related]
7. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Henry JA; Nicholson S; Hennessy C; Lennard TW; May FE; Westley BR Br J Cancer; 1990 Jan; 61(1):32-8. PubMed ID: 2153395 [TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study. Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033 [TBL] [Abstract][Full Text] [Related]
9. Analysis of hormone receptors and proliferation fraction in fine-needle aspirates from primary breast carcinomas during chemotherapy or tamoxifen treatment. Skoog L; Rutqvist LE; Wilking N Acta Oncol; 1992; 31(2):139-41. PubMed ID: 1622628 [TBL] [Abstract][Full Text] [Related]
10. Indications for primary tamoxifen therapy in elderly women with breast cancer. Gaskell DJ; Hawkins RA; de Carteret S; Chetty U; Sangster K; Forrest AP Br J Surg; 1992 Dec; 79(12):1317-20. PubMed ID: 1486428 [TBL] [Abstract][Full Text] [Related]
11. Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment. Howell A; Harland RN; Barnes DM; Baildam AD; Wilkinson MJ; Hayward E; Swindell R; Sellwood RA Cancer Res; 1987 Jan; 47(1):300-4. PubMed ID: 3791215 [TBL] [Abstract][Full Text] [Related]
12. Tumour oestrogen receptor content allows selection of elderly patients with breast cancer for conservative tamoxifen treatment. Low SC; Dixon AR; Bell J; Ellis IO; Elston CW; Robertson JF; Blamey RW Br J Surg; 1992 Dec; 79(12):1314-6. PubMed ID: 1486427 [TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical staining of pS2 protein in fine-needle aspirate from breast cancer is an accurate guide to response to tamoxifen in patients aged over 70 years. Wilson YG; Rhodes M; Ibrahim NB; Padfield CJ; Cawthorn SJ Br J Surg; 1994 Aug; 81(8):1155-8. PubMed ID: 7953346 [TBL] [Abstract][Full Text] [Related]
14. Tamoxifen therapy, oestrogen receptor status, and postmenopausal breast cancer. A'Hern RP; Wilson AJ; Baum M Lancet; 1985 Apr; 1(8435):976. PubMed ID: 2859424 [No Abstract] [Full Text] [Related]
15. Oestrogen receptors and the response of metastatic breast cancer to aminoglutethimide or tamoxifen. Holdaway IM Aust N Z J Surg; 1981 Aug; 51(4):345-7. PubMed ID: 6944051 [TBL] [Abstract][Full Text] [Related]
16. [Fine-needle aspiration biopsy and analysis of estrogen receptors in breast cancer]. Benyahia B; Magdelenat H; Zajdela A; Vilcoq JR Bull Cancer; 1982; 69(5):456-60. PubMed ID: 7165807 [TBL] [Abstract][Full Text] [Related]
17. Oestrogen receptor assay of breast cancer by immunocytochemistry of fine needle aspirates. Kitchen PR; Stillwell RG; Henderson MA; Bennett RC; Rennie GC; Kou SJ; Georgiou T; Ayberk H Aust N Z J Surg; 1991 Mar; 61(3):223-8. PubMed ID: 1848428 [TBL] [Abstract][Full Text] [Related]
18. Primary breast carcinoma: immunocytochemical and immunohistochemical evaluation of biological parameters. Sianesi M; Bozzetti C; Del Rio P; Nizzoli R; Cascinu S Chir Ital; 2000; 52(6):643-5. PubMed ID: 11199998 [TBL] [Abstract][Full Text] [Related]
19. Metastatic breast carcinoma with positive estrogen and progesterone receptors in a man with Klinefelter's syndrome. Ellison HS; Scheuer SA; Eichner ER South Med J; 1980 Oct; 73(10):1393-6. PubMed ID: 7434059 [TBL] [Abstract][Full Text] [Related]
20. Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimen from patients with breast cancer. Masood S Arch Pathol Lab Med; 1989 Jan; 113(1):26-30. PubMed ID: 2462858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]